Rose Zamoyska

11PUBLICATIONS
45CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Reaction engineering (excl. nuclear reactions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 18, 2026
CD8 T lymphocytes deploy embryonic cell cycle control mechanisms for rapid cell proliferation.

|Dec 06, 2023
Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion.

Alexandra Rose Teagle, Patricia Castro-Sanchez, Rebecca J Brownlie

|Dec 17, 2022
Translation factor eIF5a is essential for IFNγ production and cell cycle regulation in primary CD8+ T lymphocytes.

Thomas C J Tan, Van Kelly, Xiaoyan Zou

|Dec 01, 2022
Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease.

Atsushi Tanaka, Shinji Maeda, Takashi Nomura

|Feb 04, 2022
A disease-linked lncRNA mutation in RNase MRP inhibits ribosome synthesis.

Nic Robertson, Vadim Shchepachev, David Wright

|Nov 09, 2017
Resistance to TGFβ suppression and improved anti-tumor responses in CD8+ T cells lacking PTPN22.

Rebecca J Brownlie, Celine Garcia, Mate Ravasz

Pageof 2

Frequent Collaborators

3 joint publications

David Wright

2 joint publications

Rebecca J Brownlie

2 joint publications

Tony Ly

2 joint publications

Robert J Salmond